Neelesh K. Nadkarni

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease”.

Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2024)10.1001/jamaneurol.2024.0991

N/A

1.0DataRank · unranked

29 citations

Haiyan Liu, Guoqiao Wang, Xinyu Shi, Tobias Bittner, Marzia A. Scelsi +94 more

Effect of Timing and Coordination Training on Mobility and Physical Activity Among Community-Dwelling Older Adults

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.12921

N/A

0.689DataRank · unranked

24 citations

Subashan Perera, Valerie Shuman, Alexandra B. Gil, Andrea M. Kriska, Neelesh K. Nadkarni +4 more

Association ofBDNFVal66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease

JAMA Neurology(2022)10.1001/jamaneurol.2021.5181

N/A

0DataRank · unranked

37 citations

Paul Maruff, Nicolas R. Barthélemy, Alison Goate, Jason Hassenstab, Chihiro Sato +87 more

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

Nature Medicine(2023)10.1038/s41591-023-02476-4

N/A

0DataRank · unranked

179 citations

Shijia Bian, Rafi U. Haque, Kathleen Carter, Caroline M Watson, Brian A. Gordon +93 more

γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

The Lancet Neurology(2024)10.1016/s1474-4422(24)00236-9

N/A

0DataRank · unranked

33 citations

Lei Liu, Aaron P. Schultz, Colleen Fitzpatrick, Raina Levin, Jean‐Pierre Bellier +94 more

Cerebrovascular disease is associated with Alzheimer’s plasma biomarker concentrations in adults with Down syndrome

Brain Communications(2024)10.1093/braincomms/fcae331

N/A

0DataRank · unranked

29 citations

Patrick J. Lao, Mohamad J. Alshikho, Olivia M. Ericsson, Batool Rizvi, Melissa Petersen +70 more

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Nature Communications(2024)10.1038/s41467-024-52937-8

N/A

0DataRank · unranked

28 citations

Lisa M. Häsler, Marius Lambert, Stephan A. Kaeser, Susanne Gräber‐Sultan, Ulrike Obermüller +88 more

Association of inflammatory markers with muscle and cognitive function in early and late-aging older adults

The journal of nutrition health & aging(2024)10.1016/j.jnha.2024.100207

N/A

0DataRank · unranked

16 citations

Subashan Perera, Neelesh K. Nadkarni, Susan L. Greenspan, Nami Safai Haeri

Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

EBioMedicine(2024)10.1016/j.ebiom.2024.105080

N/A

0DataRank · unranked

11 citations

Austin McCullough, Brian A. Gordon, Charles D. Chen, Nicole S. McKay, Diana A. Hobbs +86 more

ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging

Alzheimer s & Dementia Translational Research & Clinical Interventions(2025)10.1002/trc2.70144

N/A

0DataRank · unranked

5 citations

Whitney Wharton, Cristina Murray‐Krezan, Minjie Wu, Yue-Fang Chang, Beth E. Snitz +20 more

Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

Acta Neuropathologica(2025)10.1007/s00401-025-02890-7

N/A

0DataRank · unranked

5 citations

Erin Franklin, Yan Li, Nelly Joseph‐Mathurin, Aime Burns, Diana A. Hobbs +93 more

A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment

Alzheimer s & Dementia(2020)10.1002/alz.12129

N/A

0DataRank · unranked

51 citations

Susan M. Sereika, Meryl A. Butters, Ann D. Cohen, William E. Klunk, Melissa Knox +6 more

A comparison of multiple amyloid PET radiotracers for Down syndrome clinical trials

Brain Communications(2025)10.1093/braincomms/fcaf406

N/A

0DataRank · unranked

2 citations

Julie C. Price, Bradley T. Christian, Michael S. Rafii, Beau M. Ances, Howard Andrews +51 more

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2020)10.1002/dad2.12018

N/A

0DataRank · unranked

45 citations

Dana Tudorascu, Zheming Yu, Elizabeth Campbell, Brian J. Lopresti, Charles M. Laymon +8 more